TILT Biotherapeutic Entered into a Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate TILT-123 for Refractory...
Shots: The companies collaborated for a P-I dose escalation trial evaluating TILT-...
Inventiva Entered into a License and Collaboration Agreement with Sino Biopharm to Develop and Commercialize Lanifibranor in Great...
Shots: Inventiva will receive $12M up front and is eligible to receive ~$5M in cli...
GSK Entered into an Exclusive License Agreement with Spero Therapeutics for Tebipenem HBr to Treat Urinary Tract Infections
Shots: Spero to receive $66M up front, ~$150M in development, ~$150M in a commerci...
Abpro Collaborated with Celltrion to Develop and Commercialize ABP 102 for the Treatment of HER2+ Cancer
Shots: Abpro to receive ~$1.75B incl. an equity investment, development, and comme...
Merck KGaA Entered into Option to License Agreement with Nerviano Medical Sciences to Develop NMS-293
Shots: NMS to receive ~$65M up front and option exercise fees & is also eligib...
CytoReason Expands its 2019 Collaboration with Pfizer for AI Drug Development
Shots: CytoReason to receive a $20M equity investment while Pfizer gets the right...
